~~<i id='7C125F0859'><strike id='7C125F0859'><tt id='7C125F0859'><pre id='7C125F0859'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：entertainment 2025-09-11 06:21:11 - browse：16

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Timeline: Special counsel's investigation into Trump's handling of classified documents

knowledge

focus

Wikipedia

knowledge

hotspot

STATWhencomedian JohnOliver tookpharmacompaniestotask onhisHBOshowSundayfortheirmarketingofpowerfuln

WSS

Genentech weighs delaying cancer therapy after drug pricing law

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

WATCH: Why do bright lights make us see spots?

Popular nasal decongestant doesn't actually relieve congestion

An innovative path out of biotech’s “valley of death”

Acelyrin, a rare IPO success, stumbles in its first big test

hotspot

leisure time

knowledge

Supreme Court strikes down use of affirmative action

GOP presidential candidates start declaring their loyalty

Heart attack and stroke risk calculators need revising

Popular nasal decongestant doesn't actually relieve congestion

23andMe had bad news about my health. I wish a person had delivered it

The history of OxyContin, told through Purdue Pharma documents

DIEP, the 'gold standard' of breast reconstruction, is under threat

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Trump demands the U.S. pay no more for drugs than other countries … again

Newly revealed memo details efforts to keep Trump in power following election loss

focus

FDA panel endorses Alnylam’s heart drug — after picking it apart

Pig kidney works a record two months in donated body

Who are the detained American citizens released from prison in Iran?

Maui funeral service workers on devastation of fires: 'I'm in shock'

Genentech weighs delaying cancer therapy after drug pricing law

Food makers tried to stack nutrition panel with preferred experts

Wikipedia

knowledge

knowledge

hotspot